Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging for Differentiation Between Parotid Neoplasms
Overview
Authors
Affiliations
Purpose: This study was designed to evaluate the role of multiparametric magnetic resonance imaging (MRI) for differentiation of parotid gland neoplasms.
Methods: Prospective study was conducted upon 52 consecutive patients (30 men, 22 women; aged 24-78 years; mean, 51 years) with parotid tumours that underwent multiparametric MRI using combined static MRI, dynamic contrast enhanced (DCE) MRI, and diffusion-weighted imaging (DWI). The static MRI parameter, time signal intensity curves (TIC) derived from DCE-MRI, and apparent diffusion coefficient (ADC) values of parotid tumours were correlated with histopathological findings.
Results: Static MRI revealed a significant difference between both benign and malignant lesions in regards to margin definition (P < .001) and T2 hypointensity (P < .013), with a diagnostic accuracy 95% and 78.33% respectively. Study of the TIC type on DCE-MRI revealed statistically significant difference between benign and malignant lesions (P < .001) and diagnostic accuracy 96.55%. There was no statistically significant difference (P = .181) between the ADC values of benign and malignant lesions. ROC curve analysis revealed that by using ADC cut-off value of 1 × 10 mm/s had accuracy of 84.62% respectively for differentiating Warthin from malignant tumours that could be modified to higher value (94.28%) by excluding lymphoma from malignant lesions. By using cutoff value of 1.3 × 10 mm/s to differentiate pleomorphic adenoma from malignancy, ROC curve analysis had high accuracy of 97.06%.
Conclusion: Multiparametric MRI can be used for differentiation of malignant from benign parotid tumours and characterization of some benign parotid tumours.
Stoia S, Ciurea A, Baciut M, Bran S, Armencea G, Botan E J Clin Med. 2025; 14(4).
PMID: 40004877 PMC: 11856562. DOI: 10.3390/jcm14041342.
Utility of diffusion tensor imaging in differentiating benign from malignant thyroid nodules.
El-Morsy A, Elmokadem A, Abdel Razek A, Ezzat Mousa A, Sakrana A, Abdel-Wahab R Neuroradiol J. 2024; 37(6):751-757.
PMID: 38864496 PMC: 11531045. DOI: 10.1177/19714009241260807.
He S, Lu R, Zhou J, Wang B, Bi G, Wu K Quant Imaging Med Surg. 2023; 13(9):6152-6163.
PMID: 37711827 PMC: 10498251. DOI: 10.21037/qims-22-1445.
Stoia S, Lenghel M, Dinu C, Tamas T, Bran S, Baciut M Cancers (Basel). 2023; 15(4).
PMID: 36831666 PMC: 9954501. DOI: 10.3390/cancers15041325.
Gokce E, Beyhan M World J Radiol. 2023; 15(1):20-31.
PMID: 36721673 PMC: 9884336. DOI: 10.4329/wjr.v15.i1.20.